The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.

Also called NCT01828359

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 199 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01828359
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01828359. Randomized; quadruple masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.
Condition
Hypertension
Intervention (Drug)
Amosartan® tab
Intervention (Drug)
Cozaar® plus pro tab
Lead sponsor
Hanmi Pharmaceutical Company Limited (class: industry)

Record details

Record id
cardio:ct-nct01828359
Content hash
9197aa64715b2452ae2a19872783d67c9f91c5266c44c334c555d1d777833000